pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-23a |
Genomic Coordinates | chr19: 13836587 - 13836659 |
Synonyms | MIRN23A, hsa-mir-23a, miRNA23A, MIR23A |
Description | Homo sapiens miR-23a stem-loop |
Comment | This miRNA was previously named miR-23 . This finding was later retracted after the discovery that the regulated gene was human homolog of ES1 (HES1), whose function is unknown. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-23a-5p | |||||||||
Sequence | 9| GGGGUUCCUGGGGAUGGGAUUU |30 | |||||||||
Evidence | Experimental | |||||||||
Experiments | Cloned | |||||||||
SNPs in miRNA |
|
|||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC35G1 | ||||||||||||||||||||
Synonyms | C10orf60, POST, TMEM20 | ||||||||||||||||||||
Description | solute carrier family 35 member G1 | ||||||||||||||||||||
Transcript | NM_001134658 | ||||||||||||||||||||
Other Transcripts | NM_153226 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC35G1 | |||||||||||||||||||||
3'UTR of SLC35G1 (miRNA target sites are highlighted) |
>SLC35G1|NM_001134658|3'UTR 1 AGCATCATTGCTGAAATACATATTTTTTTCAAGTACACCATCACCTAATTCACATACAGCATACGCACACATCTGGAAAA 81 TCTGCATTTTCTTCATTGGTTGTATTTAATAAATTGCCTAAAGTACCATTTTTGAATATAGTATGTCTTTAGTTAAGAAT 161 AGCTAGTCTGTTTGGTGTAACAATTTTTTGGTAGCTTTGGTTTTGGTTTTGGTTTTTTTTGTTGTTGTTGTTGGGGTCAA 241 GTTGGTGAGAGGAGAGCTCATTGTTTGAAGAAAAACCAAAACATTTTATGGCTAGTAATATTTATGTAATTTTTAAAATG 321 TATTTTTGGTACTGATGGGATATGGGTGGGGAGGCTATTTTAGATATTCTTTTAGCAGTGTAGAGCCTAAGAAACTTGGT 401 TCTACTACCATGATCTTTATAAACTATGCCTTCCAGACAATTGATAATGCTGCTATAATTAGTATTATGTTGATAATTCA 481 TTTGCAACCTTATTCTATTTAGGAGGATGAAGTTGAAGCTTAGAATAGGTGCCTGCTTAATGGTGTTAATAATACAAATG 561 AATTGGCCTTATTTTCAAGGATTTTATAAATGATTATCATACTTGTAACTCATATTTGTGCCTTTTCATTTTAATGCTGG 641 AATTTTTATTATGTCACCTCTAAAACACTTAAATTGCCAAATTTGGCTAGTAGTTTTGTTTCAGTGGCATTAGCAACTGC 721 AGCTAGCATACTATAATTTTAATTGTCCTCACTTTTTTTTGAAACTGCACTAAATTTTTCTTAACATTCCAAGATTTCAG 801 ATCTCTAAATCACAAAGAGAAATCTTGGCATGACCAGTGTGCACGTTTCCATCCTGAAGTGTTTTCTCTTCACTAGAAAT 881 GTGATTTTCTATAAATTCCCCTTGAATTTATAGTGTGATGCCAAATAAAATTTTCTCAGGATCTTATTAGGTTGAACCAT 961 ATGTAATTGCCAAGATTTTACTATTTTAACTTAGAAAAACCATCGTTTCATATGATTCACCCTAATAGATACCTCCATTA 1041 TTCTCTAAATGAAATAGAAGACTTTGGAGTATATGTTTTTAAAGTAATTTTTTAAAATATGGTAATGTATTAAACTTATT 1121 TTTATAGTTATGAAATTATGTGTAATAATGCTTTATGTTATACATTAAATGTAAAGACTTGTGAATCCATGTTTGATTGA 1201 CTTTCATAGTTTCCTGCATTGAAATAAAATCACTATGAATTCTAGTTTATCAGCATGATGTTAAATGTCAGTGCCATACC 1281 ATGATGCAGCACCATGACACTAACGCCATGAATTCAAACAGCACGTTTTACACCTGGAACTTCATCAGACCAATACTTTG 1361 CAGTTAGAGAGAATTTAATATCTAGAAAAGCTTGGGAGGTTAGTCAGGACTTAGGGAGTATACATAAATGGTTACTTGTT 1441 GTAATGAGCCCTTTATTGGTGAGGTTGCAATAGCTTCCAGCTCTTACTGTGTCAGATGAAGCATCTGTCATTATCTTAAG 1521 CCTGCAGAGTTGAAAGGTTATAGGCTCTTTCCTACCCTCTCATCATAATTTTTCCAAAGCAAAGAGGAACTTGGCTTCTG 1601 GGGTTCGTGCCTTAGTGAGAAAGAATCTTTTCCAATAGTTCCAATGGGGGAATTTTTGGCTTGCTGATTTTATCAATTGC 1681 CTTGACACCTGACAAACCCTAAATGAAGTCTATGTAGGTGAGTCATCTCTGTTCCACCTGATTTACAGTATTGGAATTTA 1761 GACTTGCAAAAACATCATTCTGCAAATATCTTAGATAATTACAGAATCAGGAGCATTTGAGAACTCTAGAGGTCTCAGAA 1841 ATCATCACATAGGGGCCATGCTTCGTAGATAGGGATGATAGAGAGGAGACCTGCCCAAGTTGAATTTCCATGGCCTTCCT 1921 CCCTTCCTTAGTTCCATGATAAAGTATGGACAGTAAACCACTACTTGAGCTACCTAAGGTGAATTAACTCTCAGGGAACC 2001 CTCTTCCAGTTCTTTACCTTGCACAGTGAAAGAATCAGTGGCACCTAGAAAGTTAAATCCCTTTAGGCCCATACACTAGA 2081 GACATGTTTTGTTTGAACAATGTAGTTTAAGTACTTGAATGTCACACTATATAACTGAGGTTAGAGAAAATGTTTCTTCT 2161 AGCCCTTACAGGGTGTGATTCTTAAACACAATGTCCAAGGTGTATACAAGGATATGTATTGTAACAACTATGGGTATGTA 2241 TATTTTGCAGAGCGTAGTTTCTATATCTTGAAAAGGAAAATATTTTCATAAATTGTTTTTATAAGTACTAATAAAATAAT 2321 ATGAAAGAAAGCTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000371408.3 | 3UTR | CUACCUAAGGUGAAUUAACUCUCAGGGAACCCUCUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
131 hsa-miR-23a-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038958 | ATF1 | activating transcription factor 1 | 1 | 1 | ||||||||
MIRT057661 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT395438 | NFKBID | NFKB inhibitor delta | 2 | 2 | ||||||||
MIRT463884 | WNT7B | Wnt family member 7B | 2 | 4 | ||||||||
MIRT475804 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT478528 | CTNS | cystinosin, lysosomal cystine transporter | 2 | 2 | ||||||||
MIRT479278 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 6 | ||||||||
MIRT492564 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | 2 | 2 | ||||||||
MIRT500353 | ZNF385A | zinc finger protein 385A | 2 | 2 | ||||||||
MIRT509788 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 4 | ||||||||
MIRT511566 | HIST3H2BB | histone cluster 3 H2B family member b | 2 | 4 | ||||||||
MIRT525450 | GPATCH2L | G-patch domain containing 2 like | 2 | 2 | ||||||||
MIRT539558 | CNKSR3 | CNKSR family member 3 | 2 | 4 | ||||||||
MIRT540034 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | 2 | 4 | ||||||||
MIRT540225 | SAMD5 | sterile alpha motif domain containing 5 | 2 | 2 | ||||||||
MIRT540242 | RGS17 | regulator of G protein signaling 17 | 2 | 2 | ||||||||
MIRT540871 | ZBTB24 | zinc finger and BTB domain containing 24 | 2 | 2 | ||||||||
MIRT559065 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 4 | ||||||||
MIRT560685 | HIST1H1T | histone cluster 1 H1 family member t | 2 | 2 | ||||||||
MIRT565593 | SLC35G1 | solute carrier family 35 member G1 | 2 | 2 | ||||||||
MIRT565642 | SKI | SKI proto-oncogene | 2 | 2 | ||||||||
MIRT576747 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT607712 | LIMS1 | LIM zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT615682 | NAV2 | neuron navigator 2 | 2 | 2 | ||||||||
MIRT617337 | ZSCAN2 | zinc finger and SCAN domain containing 2 | 2 | 2 | ||||||||
MIRT617378 | FAM227A | family with sequence similarity 227 member A | 2 | 2 | ||||||||
MIRT620855 | SERPING1 | serpin family G member 1 | 2 | 2 | ||||||||
MIRT625112 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT625124 | NUP93 | nucleoporin 93 | 2 | 2 | ||||||||
MIRT625898 | LINC00632 | long intergenic non-protein coding RNA 632 | 2 | 2 | ||||||||
MIRT626016 | XRCC2 | X-ray repair cross complementing 2 | 2 | 2 | ||||||||
MIRT626481 | ADAT1 | adenosine deaminase, tRNA specific 1 | 2 | 2 | ||||||||
MIRT626573 | MED7 | mediator complex subunit 7 | 2 | 2 | ||||||||
MIRT626814 | PRR11 | proline rich 11 | 2 | 2 | ||||||||
MIRT628136 | HM13 | histocompatibility minor 13 | 2 | 2 | ||||||||
MIRT630771 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | 2 | 2 | ||||||||
MIRT633133 | C6orf132 | chromosome 6 open reading frame 132 | 2 | 2 | ||||||||
MIRT636950 | APTX | aprataxin | 2 | 2 | ||||||||
MIRT637802 | GGPS1 | geranylgeranyl diphosphate synthase 1 | 2 | 2 | ||||||||
MIRT638622 | GSR | glutathione-disulfide reductase | 2 | 4 | ||||||||
MIRT642196 | SMAGP | small cell adhesion glycoprotein | 2 | 2 | ||||||||
MIRT645121 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT645344 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT646564 | ALDH5A1 | aldehyde dehydrogenase 5 family member A1 | 2 | 2 | ||||||||
MIRT649243 | TRIM65 | tripartite motif containing 65 | 2 | 2 | ||||||||
MIRT651810 | USP49 | ubiquitin specific peptidase 49 | 2 | 2 | ||||||||
MIRT652137 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | 2 | 2 | ||||||||
MIRT652668 | TIMELESS | timeless circadian clock | 2 | 2 | ||||||||
MIRT655894 | NEK9 | NIMA related kinase 9 | 2 | 2 | ||||||||
MIRT656564 | LYRM7 | LYR motif containing 7 | 2 | 2 | ||||||||
MIRT657194 | IKZF3 | IKAROS family zinc finger 3 | 2 | 2 | ||||||||
MIRT657907 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT660207 | BMPR1A | bone morphogenetic protein receptor type 1A | 2 | 2 | ||||||||
MIRT660619 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT660826 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT660986 | ABHD2 | abhydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT662232 | PGBD4 | piggyBac transposable element derived 4 | 2 | 2 | ||||||||
MIRT663691 | ZNF347 | zinc finger protein 347 | 2 | 2 | ||||||||
MIRT665577 | TUBD1 | tubulin delta 1 | 2 | 2 | ||||||||
MIRT666149 | SP2 | Sp2 transcription factor | 2 | 2 | ||||||||
MIRT666310 | SLC22A3 | solute carrier family 22 member 3 | 2 | 2 | ||||||||
MIRT666457 | SCRG1 | stimulator of chondrogenesis 1 | 2 | 2 | ||||||||
MIRT667716 | KIAA1468 | KIAA1468 | 2 | 2 | ||||||||
MIRT668329 | FKBP5 | FK506 binding protein 5 | 2 | 2 | ||||||||
MIRT668370 | FBXO47 | F-box protein 47 | 2 | 2 | ||||||||
MIRT669304 | C17orf75 | chromosome 17 open reading frame 75 | 2 | 2 | ||||||||
MIRT669538 | ALG9 | ALG9, alpha-1,2-mannosyltransferase | 2 | 2 | ||||||||
MIRT671681 | ADK | adenosine kinase | 2 | 2 | ||||||||
MIRT672177 | MRE11A | MRE11 homolog, double strand break repair nuclease | 2 | 2 | ||||||||
MIRT673604 | HPSE | heparanase | 2 | 2 | ||||||||
MIRT673749 | ZNF333 | zinc finger protein 333 | 2 | 2 | ||||||||
MIRT674807 | FAM229B | family with sequence similarity 229 member B | 2 | 2 | ||||||||
MIRT675286 | ARL10 | ADP ribosylation factor like GTPase 10 | 2 | 2 | ||||||||
MIRT675391 | SVOP | SV2 related protein | 2 | 2 | ||||||||
MIRT675788 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT676151 | OGFOD1 | 2-oxoglutarate and iron dependent oxygenase domain containing 1 | 2 | 2 | ||||||||
MIRT676499 | GJD3 | gap junction protein delta 3 | 2 | 2 | ||||||||
MIRT676621 | CSNK1E | casein kinase 1 epsilon | 2 | 2 | ||||||||
MIRT676644 | GTDC1 | glycosyltransferase like domain containing 1 | 2 | 2 | ||||||||
MIRT676711 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT676809 | SHROOM4 | shroom family member 4 | 2 | 2 | ||||||||
MIRT677036 | FOXO3 | forkhead box O3 | 2 | 2 | ||||||||
MIRT677062 | NT5C2 | 5'-nucleotidase, cytosolic II | 2 | 2 | ||||||||
MIRT677086 | SMIM15 | small integral membrane protein 15 | 2 | 2 | ||||||||
MIRT677193 | MURC | caveolae associated protein 4 | 2 | 2 | ||||||||
MIRT677273 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT677345 | POC1A | POC1 centriolar protein A | 2 | 2 | ||||||||
MIRT677504 | SLC10A6 | solute carrier family 10 member 6 | 2 | 2 | ||||||||
MIRT677526 | OCIAD2 | OCIA domain containing 2 | 2 | 2 | ||||||||
MIRT677661 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2 | 2 | ||||||||
MIRT677727 | SSR1 | signal sequence receptor subunit 1 | 2 | 2 | ||||||||
MIRT677803 | PNPLA3 | patatin like phospholipase domain containing 3 | 2 | 2 | ||||||||
MIRT678144 | SLC4A4 | solute carrier family 4 member 4 | 2 | 2 | ||||||||
MIRT678376 | VTA1 | vesicle trafficking 1 | 2 | 2 | ||||||||
MIRT678708 | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | 2 | 2 | ||||||||
MIRT678868 | FAM118A | family with sequence similarity 118 member A | 2 | 2 | ||||||||
MIRT679039 | LACTB | lactamase beta | 2 | 2 | ||||||||
MIRT679081 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT679137 | SYK | spleen associated tyrosine kinase | 2 | 2 | ||||||||
MIRT679299 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT679741 | CABP4 | calcium binding protein 4 | 2 | 2 | ||||||||
MIRT679946 | AS3MT | arsenite methyltransferase | 2 | 2 | ||||||||
MIRT679976 | E2F2 | E2F transcription factor 2 | 2 | 2 | ||||||||
MIRT683628 | MTO1 | mitochondrial tRNA translation optimization 1 | 2 | 2 | ||||||||
MIRT683901 | PSMB9 | proteasome subunit beta 9 | 2 | 2 | ||||||||
MIRT684172 | MOG | myelin oligodendrocyte glycoprotein | 2 | 2 | ||||||||
MIRT684231 | C20orf144 | chromosome 20 open reading frame 144 | 2 | 2 | ||||||||
MIRT685403 | C1orf158 | chromosome 1 open reading frame 158 | 2 | 2 | ||||||||
MIRT686253 | ZBTB8B | zinc finger and BTB domain containing 8B | 2 | 2 | ||||||||
MIRT687513 | NCKAP1 | NCK associated protein 1 | 2 | 2 | ||||||||
MIRT688243 | FITM2 | fat storage inducing transmembrane protein 2 | 2 | 2 | ||||||||
MIRT688315 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT688733 | CNDP1 | carnosine dipeptidase 1 | 2 | 2 | ||||||||
MIRT689031 | ANGPTL3 | angiopoietin like 3 | 2 | 2 | ||||||||
MIRT698207 | TMEM248 | transmembrane protein 248 | 2 | 2 | ||||||||
MIRT699859 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT709954 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT711541 | MSH3 | mutS homolog 3 | 2 | 2 | ||||||||
MIRT712077 | WDR37 | WD repeat domain 37 | 2 | 2 | ||||||||
MIRT715312 | POLR2E | RNA polymerase II subunit E | 2 | 2 | ||||||||
MIRT715725 | PIAS2 | protein inhibitor of activated STAT 2 | 2 | 2 | ||||||||
MIRT715748 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | 2 | 2 | ||||||||
MIRT717604 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT717875 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT718042 | NIPAL2 | NIPA like domain containing 2 | 2 | 2 | ||||||||
MIRT718829 | CDT1 | chromatin licensing and DNA replication factor 1 | 2 | 2 | ||||||||
MIRT724037 | CAMK2N2 | calcium/calmodulin dependent protein kinase II inhibitor 2 | 2 | 2 | ||||||||
MIRT733305 | TNF | tumor necrosis factor | 1 | 0 | ||||||||
MIRT734941 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 3 | 0 | ||||||||
MIRT737343 | IGF2 | insulin like growth factor 2 | 3 | 0 | ||||||||
MIRT737546 | PTEN | phosphatase and tensin homolog | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|